Hedy Kindler

Hedy Kindler has dedicated her career to advancing treatment for malignant mesothelioma and rare gastrointestinal cancers. She has conducted numerous pivotal clinical trials in mesothelioma that established standards of care and identified effective systemic therapies. Her research encompasses both pleural and peritoneal mesothelioma subtypes. She is a leading advocate for patients with rare thoracic malignancies and has mentored many thoracic oncology specialists.